Fetal public Vγ9Vδ2 T cells expand and gain potent cytotoxic functions early after birth

Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18638-18648. doi: 10.1073/pnas.1922595117. Epub 2020 Jul 14.

Abstract

Vγ9Vδ2 T cells are a major human blood γδ T cell population that respond in a T cell receptor (TCR)-dependent manner to phosphoantigens which are generated by a variety of microorganisms. It is not clear how Vγ9Vδ2 T cells react toward the sudden microbial exposure early after birth. We found that human Vγ9Vδ2 T cells with a public/shared fetal-derived TCR repertoire expanded within 10 wk postpartum. Such an expansion was not observed in non-Vγ9Vδ2 γδ T cells, which possessed a private TCR repertoire. Furthermore, only the Vγ9Vδ2 T cells differentiated into potent cytotoxic effector cells by 10 wk of age, despite their fetal origin. Both the expansion of public fetal Vγ9Vδ2 T cells and their functional differentiation were not affected by newborn vaccination with the phosphoantigen-containing bacillus Calmette-Guérin (BCG) vaccine. These findings suggest a strong and early priming of the public fetal-derived Vγ9Vδ2 T cells promptly after birth, likely upon environmental phosphoantigen exposure.

Keywords: TCR repertoire; Vγ9Vδ2; gammadelta; infant; newborn.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • BCG Vaccine / immunology
  • Cells, Cultured
  • Cytokines / metabolism
  • Female
  • Fetus / immunology
  • Humans
  • Infant
  • Infant, Newborn
  • Pregnancy
  • Receptors, Antigen, T-Cell, gamma-delta / immunology*
  • T-Lymphocyte Subsets / immunology*
  • T-Lymphocytes, Cytotoxic / immunology*

Substances

  • BCG Vaccine
  • Cytokines
  • Receptors, Antigen, T-Cell, gamma-delta